Shenzhen Bioeasy Biotechnology Co., Ltd.

SZSE:300942.SZ

11.43 (CNY) • At close October 26, 2023
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q1
Omzet 54.466.99236.37489.00752.98851.40460.708114.80397.426180.668294.001166.467100.583183.573146.91871.96154.90859.37772.2195.27242.854
Kosten van de omzet 21.08126.3299.25842.58816.61422.50845.523125.1451.74171.71896.40864.94629.85251.28723.42624.7713.21214.36211.32425.23712.946
Brutowinst 33.31840.66327.11546.41936.37428.89615.185-10.33745.685108.949197.593101.52170.731132.286123.49247.19241.69645.01560.88570.03529.907
Brutowinstmarge 0.6120.6070.7450.5220.6860.5620.25-0.090.4690.6030.6720.610.7030.7210.8410.6560.7590.7580.8430.7350.698
Onderzoek- en ontwikkelingskosten 8.6838.18610.2814.5348.10222.11618.39250.87319.8225.11915.60626.69415.55819.4910.699.98411.63110.4788.3710.2156.115
Algemene en administratieve kosten 29.628-6.14512.772-37.77634.38813.17213.9814.11750.45612.50823.386-15.51325.743-3.64112.6113.22130.756-20.245.982-46.8775.309
Verkoop- en marketingkosten 24.11513.4849.7323.74613.65122.73416.6223.9316.64419.45118.5216.4218.09513.7399.8256.00910.0479.9446.23612.5357.003
Verkoop-, algemene en administratieve kosten 53.74328.37621.958-34.0348.03835.90630.60213.84467.09931.9641.9060.90833.83910.09822.4359.2340.802-10.29612.218-34.34212.312
Overige kosten -35.31900.013-1.344-0.95-0.2930.0910-0.0030.0150.028-6.005-0.2620.0136.017-0.0352.691-3.8190.001-2.895-0.198
Bedrijfskosten 27.10737.72632.23836.48536.93872.90147.40464.1961.0275.77655.09652.85133.70243.42830.10122.8825.65933.93919.76726.10116.16
Bedrijfsresultaat 6.2126.198-5.123-80.215-11.293-50.259-33.534-87.182-8.54145.297139.2844.2541.23487.28295.51116.12313.4224.64640.91444.25214.952
Bedrijfsresultaat ratio 0.1140.093-0.141-0.901-0.213-0.978-0.552-0.759-0.0880.2510.4740.2660.410.4750.650.2240.2440.0780.5670.4640.349
Totaal overige inkomsten en kosten netto -0.254-0.107-0.047-54.913-0.819-0.2930.0915.9925.038.6362.898.2783.0360.9036.099-4.5641.6735.206-0.2035.762-0.198
Inkomen voor belasting 5.9576.092-5.17-81.559-12.244-50.552-33.443-81.19-8.54445.312139.30838.24540.97287.295101.52816.08813.4193.52140.91544.28414.755
Inkomen voor belasting ratio 0.110.091-0.142-0.916-0.231-0.983-0.551-0.707-0.0880.2510.4740.230.4070.4760.6910.2240.2440.0590.5670.4650.344
Belastingkosten 1.0170.771-0.0564.20817.297-8.961-5.35815.562-5.4778.05125.21-2.5938.63111.60313.9282.5480.707-0.6545.8936.2011.682
Nettowinst 5.4565.552-7.111-85.749-29.526-41.571-28.061-65.399-3.04937.285114.12940.84632.35375.69887.6113.5512.6814.18435.03138.08713.081
Nettowinstmarge 0.10.083-0.195-0.963-0.557-0.809-0.462-0.57-0.0310.2060.3880.2450.3220.4120.5960.1880.2310.070.4850.40.305
WPA (Winst Per Aandeel) 0.0140.014-0.018-0.22-0.074-0.1-0.07-0.17-0.0080.0930.280.10.0790.190.230.040.0320.0130.090.110.04
Verwaterde WPA 0.0140.014-0.018-0.22-0.074-0.1-0.07-0.17-0.0080.0930.280.10.0790.190.230.040.0320.0130.090.110.04
EBITDA 9.7618.162-1.935-35.117-5.183-34.8-32.263-84.3163.11553.194147.1748.16949.82894.072108.11118.43114.9655.12242.88343.93411.533
EBITDA ratio 0.1790.271-0.076-0.395-0.098-0.695-0.56-0.734-0.0920.2660.490.250.3820.4810.6880.3260.2430.0720.570.4810.355